NCT01932853已完成不适用
Evaluation of the Association of Dialysis Dose Obtained by Kt and Mortality in Hemodialysis Patients
NephroCare Spain1 个研究点 分布在 1 个国家目标入组 6,129 人开始时间: 2013年10月最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 6,129
- 试验地点
- 1
- 主要终点
- Mortality
研究概览
简要总结
The aim of this study is to assess whether patients receiving current recommendations of an adequate dialysis dose by Kt adjusted for body surface area improved survival at 24 months compared to those who do not get it, as well as assess whether patients receiving a dose greater obtain more benefit.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •> 18 years old
- •> six months on hemodialysis
- •Receiving 3 sessions of dialysis per week
- •Having 5 or more valid measures of Kt during the month
排除标准
- •active chronic inflammatory diseases
- •Liver cirrhosis
- •Neoplasms
- •Chronic immunosuppression or use of anti-inflammatory
结局指标
主要结局
Mortality
时间窗: two years
次要结局
- Hospitalization(two years)
研究者
Rosa Ramos
MD, Ph
NephroCare Spain
研究点 (1)
Loading locations...
相似试验
进行中（未招募）
不适用
Clinical Validation Study for Optimization of Anemia MAnagement in Hemodialysis Patients With End Stage Kidney Disease Using the Dialysis Anemia TReatmenT ModelDialysisNCT05936021Intermountain Health Care, Inc.80
已完成
不适用
In DIAlysis patient study of efficacy and safety of MONthly minoDoronateJPRN-UMIN000010185Oita university facility of medicine50
已完成
4 期
Pharmacokinetics, Safety And Toleration Of Maraviroc Administered To Subjects With Various Degrees Of Renal Impaired And Normal Renal FunctionHuman Immunodeficiency Virus (HIV) InfectionNCT00717067ViiV Healthcare30
已完成
不适用
HeRO Graft Compared to Permanent Catheters for End Stage Renal Disease (ESRD) Patients Receiving HemodialysisEnd Stage Renal Disease (ESRD)NCT01343251Merit Medical Systems, Inc.33
已完成
不适用
Monitoring in Dialysis -- a Prospective, Multi-center, Single-arm, Non-randomized, Observational Study in Patients Who Are Undergoing Hemodialysis.End Stage Renal DiseaseNCT01779856Medtronic Corporate Technologies and New Ventures81